Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway
- 16 May 2020
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 880, 173142
- https://doi.org/10.1016/j.ejphar.2020.173142
Abstract
No abstract availableKeywords
Funding Information
- Cape Peninsula University of Technology
- National Research Foundation
This publication has 90 references indexed in Scilit:
- Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension EtiologyJournal of the American Heart Association, 2013
- Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patientsNephrology, 2012
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal functionKidney International, 2011
- Flavonoids lower Alzheimer's Aß production via an NFkB dependent mechanismBioinformation, 2011
- Peroxynitrite mediates right-ventricular dysfunction in nitric oxide-exposed juvenile ratsFree Radical Biology & Medicine, 2010
- New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Mineralocorticoid-Receptor Blockers Exert Antihypertensive and Renoprotective Effects Independently of the Renin–Angiotensin SystemJournal of Pharmacological Sciences, 2010
- Mineralocorticoid receptor activation in obesity hypertensionHypertension Research, 2009
- The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk FactorsPLoS Medicine, 2009
- Effect of alpha-lipoic acid supplementation on markers of protein oxidation in post-mitotic tissues of ageing ratCell Biochemistry and Function, 2004
- Monocyte Chemoattractant Protein-1 Induces Proliferation and Interleukin-6 Production in Human Smooth Muscle Cells by Differential Activation of Nuclear Factor-κB and Activator Protein-1Arteriosclerosis, Thrombosis, and Vascular Biology, 2002